Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electroencephalography | 73 | 2023 | 6150 | 2.700 |
Why?
|
Epilepsy | 41 | 2023 | 3310 | 1.630 |
Why?
|
Epilepsies, Partial | 15 | 2008 | 436 | 1.190 |
Why?
|
Monitoring, Ambulatory | 5 | 2021 | 355 | 1.030 |
Why?
|
Status Epilepticus | 7 | 2011 | 444 | 1.010 |
Why?
|
Epilepsy, Temporal Lobe | 17 | 2012 | 403 | 1.010 |
Why?
|
Electrodes | 9 | 2020 | 619 | 0.900 |
Why?
|
Electrophysiological Phenomena | 3 | 2021 | 315 | 0.720 |
Why?
|
Biophysical Phenomena | 1 | 2020 | 327 | 0.710 |
Why?
|
Anticonvulsants | 17 | 2022 | 1916 | 0.700 |
Why?
|
Cerebral Cortex | 17 | 2021 | 5708 | 0.620 |
Why?
|
Telemetry | 4 | 2006 | 205 | 0.610 |
Why?
|
Diagnosis, Computer-Assisted | 4 | 2011 | 719 | 0.600 |
Why?
|
Temporal Lobe | 10 | 2012 | 1670 | 0.540 |
Why?
|
Artifacts | 5 | 2011 | 1904 | 0.480 |
Why?
|
Evoked Potentials, Visual | 6 | 2015 | 427 | 0.450 |
Why?
|
Monitoring, Physiologic | 9 | 2004 | 1738 | 0.400 |
Why?
|
Brain Mapping | 13 | 2020 | 6669 | 0.380 |
Why?
|
Signal Processing, Computer-Assisted | 6 | 2015 | 1534 | 0.380 |
Why?
|
Brain | 23 | 2018 | 26385 | 0.370 |
Why?
|
Convulsants | 3 | 2000 | 70 | 0.370 |
Why?
|
Brain Diseases | 4 | 2011 | 1563 | 0.360 |
Why?
|
Theta Rhythm | 4 | 2018 | 207 | 0.340 |
Why?
|
Phenytoin | 6 | 2022 | 197 | 0.340 |
Why?
|
Seizures | 12 | 2018 | 2859 | 0.320 |
Why?
|
Sexual Dysfunction, Physiological | 5 | 2010 | 360 | 0.310 |
Why?
|
Epilepsy, Generalized | 2 | 2000 | 174 | 0.300 |
Why?
|
Critical Care | 2 | 2011 | 2647 | 0.290 |
Why?
|
Galactosemias | 2 | 2020 | 125 | 0.260 |
Why?
|
Electrodes, Implanted | 9 | 2016 | 824 | 0.260 |
Why?
|
Intelligence Tests | 2 | 2022 | 505 | 0.260 |
Why?
|
Computer Systems | 2 | 2003 | 483 | 0.250 |
Why?
|
Neurons | 13 | 2021 | 9338 | 0.240 |
Why?
|
Gonadotropins, Pituitary | 1 | 2003 | 73 | 0.240 |
Why?
|
Flurothyl | 3 | 2000 | 10 | 0.230 |
Why?
|
Semantics | 3 | 2015 | 584 | 0.230 |
Why?
|
Physicians | 2 | 2021 | 4567 | 0.220 |
Why?
|
Echo-Planar Imaging | 3 | 1999 | 659 | 0.220 |
Why?
|
Aspartame | 2 | 2002 | 18 | 0.220 |
Why?
|
Gonadal Steroid Hormones | 2 | 2005 | 712 | 0.220 |
Why?
|
Menstruation Disturbances | 2 | 2003 | 148 | 0.220 |
Why?
|
Proto-Oncogene Proteins c-fos | 3 | 2000 | 575 | 0.210 |
Why?
|
Scalp | 2 | 2012 | 380 | 0.210 |
Why?
|
Reading | 2 | 2003 | 558 | 0.200 |
Why?
|
Adult | 82 | 2023 | 214055 | 0.200 |
Why?
|
N-Glycosyl Hydrolases | 1 | 2000 | 68 | 0.190 |
Why?
|
Panic Disorder | 2 | 1995 | 616 | 0.190 |
Why?
|
Acetylcholinesterase | 1 | 2000 | 153 | 0.190 |
Why?
|
Neurology | 2 | 2022 | 763 | 0.180 |
Why?
|
Immunotoxins | 1 | 2000 | 179 | 0.180 |
Why?
|
Humans | 117 | 2023 | 744343 | 0.180 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2003 | 703 | 0.170 |
Why?
|
Delta Rhythm | 2 | 2018 | 78 | 0.170 |
Why?
|
Event-Related Potentials, P300 | 1 | 2000 | 150 | 0.170 |
Why?
|
Magnetoencephalography | 3 | 2006 | 623 | 0.170 |
Why?
|
Epilepsy, Complex Partial | 4 | 2006 | 62 | 0.160 |
Why?
|
Prosencephalon | 1 | 2000 | 303 | 0.160 |
Why?
|
Entorhinal Cortex | 3 | 2010 | 272 | 0.160 |
Why?
|
Agraphia | 1 | 1998 | 8 | 0.160 |
Why?
|
Neurites | 1 | 2020 | 388 | 0.160 |
Why?
|
Plant Proteins | 1 | 2000 | 364 | 0.160 |
Why?
|
Intelligence | 1 | 2003 | 920 | 0.160 |
Why?
|
Brain Waves | 2 | 2013 | 401 | 0.160 |
Why?
|
Microelectrodes | 7 | 2021 | 303 | 0.160 |
Why?
|
Self Care | 5 | 2008 | 786 | 0.160 |
Why?
|
Evoked Potentials | 6 | 2011 | 1056 | 0.150 |
Why?
|
Male | 69 | 2023 | 350118 | 0.150 |
Why?
|
Mental Recall | 3 | 2010 | 1205 | 0.150 |
Why?
|
Oxygen | 3 | 2000 | 4189 | 0.150 |
Why?
|
Auditory Pathways | 1 | 1999 | 233 | 0.150 |
Why?
|
Behavior | 2 | 2002 | 561 | 0.140 |
Why?
|
Female | 62 | 2022 | 380194 | 0.140 |
Why?
|
Middle Aged | 47 | 2021 | 213383 | 0.140 |
Why?
|
Mental Processes | 2 | 2009 | 249 | 0.140 |
Why?
|
Pattern Recognition, Visual | 3 | 1997 | 824 | 0.140 |
Why?
|
Frontal Lobe | 5 | 2009 | 1406 | 0.130 |
Why?
|
Memory Disorders | 3 | 2010 | 1184 | 0.130 |
Why?
|
Cerebral Veins | 1 | 2016 | 156 | 0.130 |
Why?
|
Nervous System | 1 | 1998 | 554 | 0.130 |
Why?
|
Hypogonadism | 4 | 2010 | 799 | 0.130 |
Why?
|
Carbamazepine | 6 | 2022 | 229 | 0.130 |
Why?
|
Reaction Time | 2 | 2006 | 2097 | 0.120 |
Why?
|
Analysis of Variance | 6 | 2009 | 6365 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 20 | 2021 | 35421 | 0.120 |
Why?
|
Brain Stem | 1 | 1999 | 846 | 0.120 |
Why?
|
Adolescent | 27 | 2021 | 85781 | 0.120 |
Why?
|
Information Theory | 1 | 2013 | 51 | 0.110 |
Why?
|
Hippocampus | 5 | 2010 | 3675 | 0.110 |
Why?
|
Terminology as Topic | 1 | 2020 | 1547 | 0.110 |
Why?
|
Testosterone | 7 | 2010 | 2420 | 0.100 |
Why?
|
Neurosurgical Procedures | 2 | 2016 | 2002 | 0.100 |
Why?
|
Algorithms | 3 | 2011 | 13881 | 0.100 |
Why?
|
Triazines | 4 | 2006 | 315 | 0.100 |
Why?
|
Young Adult | 12 | 2021 | 56430 | 0.100 |
Why?
|
Coma | 2 | 2011 | 475 | 0.100 |
Why?
|
Luteinizing Hormone | 7 | 2005 | 869 | 0.100 |
Why?
|
Predictive Value of Tests | 6 | 2012 | 15076 | 0.100 |
Why?
|
Quality of Life | 1 | 2012 | 12804 | 0.090 |
Why?
|
Thalamus | 1 | 2016 | 1023 | 0.090 |
Why?
|
Diagnosis, Differential | 3 | 2021 | 12959 | 0.090 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2020 | 2737 | 0.090 |
Why?
|
Dominance, Cerebral | 5 | 2006 | 635 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2214 | 0.090 |
Why?
|
Estradiol | 5 | 2006 | 2020 | 0.090 |
Why?
|
Kluver-Bucy Syndrome | 1 | 2009 | 9 | 0.090 |
Why?
|
Amygdala | 2 | 1997 | 1315 | 0.090 |
Why?
|
Functional Laterality | 5 | 2010 | 2290 | 0.090 |
Why?
|
Sex Hormone-Binding Globulin | 3 | 2005 | 548 | 0.090 |
Why?
|
Memory | 2 | 2010 | 2174 | 0.090 |
Why?
|
Periodicity | 2 | 2010 | 363 | 0.090 |
Why?
|
Cognition | 4 | 2011 | 6770 | 0.090 |
Why?
|
Linguistics | 1 | 2009 | 97 | 0.090 |
Why?
|
Melatonin | 1 | 1995 | 721 | 0.090 |
Why?
|
Aged | 21 | 2016 | 163280 | 0.080 |
Why?
|
Electric Stimulation | 3 | 2021 | 1767 | 0.080 |
Why?
|
Sphenoid Bone | 2 | 2003 | 172 | 0.080 |
Why?
|
Drug Therapy, Combination | 3 | 2010 | 6489 | 0.080 |
Why?
|
Sleep | 3 | 2018 | 4623 | 0.080 |
Why?
|
Computers | 1 | 1991 | 612 | 0.080 |
Why?
|
Head | 3 | 2010 | 880 | 0.080 |
Why?
|
Reference Values | 5 | 2000 | 4982 | 0.080 |
Why?
|
Computer Terminals | 1 | 2008 | 44 | 0.080 |
Why?
|
Reproducibility of Results | 6 | 2023 | 19905 | 0.080 |
Why?
|
Nursing Assessment | 2 | 2008 | 107 | 0.080 |
Why?
|
Self Efficacy | 3 | 2006 | 616 | 0.070 |
Why?
|
Sensitivity and Specificity | 5 | 2008 | 14722 | 0.070 |
Why?
|
Risk Assessment | 1 | 2008 | 23338 | 0.070 |
Why?
|
Aged, 80 and over | 8 | 2013 | 57776 | 0.070 |
Why?
|
Time Factors | 12 | 2010 | 40075 | 0.070 |
Why?
|
Psychology | 1 | 2008 | 356 | 0.070 |
Why?
|
Transcranial Magnetic Stimulation | 3 | 2009 | 1432 | 0.070 |
Why?
|
Visual Perception | 1 | 2015 | 1420 | 0.070 |
Why?
|
Language | 2 | 2020 | 1471 | 0.070 |
Why?
|
Video Recording | 2 | 2023 | 949 | 0.070 |
Why?
|
Malformations of Cortical Development | 1 | 2008 | 200 | 0.070 |
Why?
|
Aromatase Inhibitors | 1 | 2010 | 491 | 0.070 |
Why?
|
Psycholinguistics | 1 | 2006 | 78 | 0.070 |
Why?
|
Migraine Disorders | 1 | 1998 | 1620 | 0.070 |
Why?
|
Vagus Nerve Stimulation | 1 | 2008 | 199 | 0.070 |
Why?
|
Anterior Temporal Lobectomy | 1 | 2005 | 48 | 0.060 |
Why?
|
Preoperative Care | 2 | 2006 | 2250 | 0.060 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 3 | 2009 | 1107 | 0.060 |
Why?
|
Nitriles | 1 | 2010 | 956 | 0.060 |
Why?
|
Speech | 1 | 2009 | 540 | 0.060 |
Why?
|
Paraneoplastic Syndromes | 2 | 1997 | 151 | 0.060 |
Why?
|
Models, Psychological | 2 | 2008 | 811 | 0.060 |
Why?
|
Neuropsychological Tests | 6 | 2020 | 6993 | 0.060 |
Why?
|
Triazoles | 1 | 2010 | 911 | 0.060 |
Why?
|
Technology Assessment, Biomedical | 1 | 2006 | 306 | 0.060 |
Why?
|
Patient Compliance | 2 | 2005 | 2684 | 0.060 |
Why?
|
Hemianopsia | 1 | 2005 | 122 | 0.060 |
Why?
|
Membrane Potentials | 1 | 2007 | 1137 | 0.060 |
Why?
|
Verbal Learning | 1 | 2006 | 467 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4042 | 0.050 |
Why?
|
Polypharmacy | 1 | 2005 | 294 | 0.050 |
Why?
|
Action Potentials | 1 | 2010 | 1806 | 0.050 |
Why?
|
Anisotropy | 2 | 2020 | 1265 | 0.050 |
Why?
|
Internship and Residency | 1 | 2022 | 5788 | 0.050 |
Why?
|
Electromagnetic Fields | 1 | 2004 | 298 | 0.050 |
Why?
|
Psychomotor Performance | 3 | 2009 | 1901 | 0.050 |
Why?
|
Occipital Lobe | 1 | 2003 | 379 | 0.050 |
Why?
|
Prognosis | 3 | 2011 | 29063 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 4 | 2000 | 8301 | 0.050 |
Why?
|
Wavelet Analysis | 1 | 2021 | 57 | 0.050 |
Why?
|
Sex Chromosome Aberrations | 1 | 2001 | 114 | 0.050 |
Why?
|
Face | 2 | 1997 | 994 | 0.050 |
Why?
|
Steroids | 1 | 2006 | 930 | 0.050 |
Why?
|
Evaluation Studies as Topic | 1 | 2004 | 1681 | 0.050 |
Why?
|
Phenobarbital | 1 | 2022 | 193 | 0.050 |
Why?
|
Stereotyping | 1 | 2003 | 241 | 0.050 |
Why?
|
Age Factors | 5 | 2010 | 18370 | 0.050 |
Why?
|
Ribosome Inactivating Proteins, Type 1 | 1 | 2000 | 27 | 0.050 |
Why?
|
Social Support | 2 | 2008 | 2118 | 0.050 |
Why?
|
Acoustic Stimulation | 2 | 2021 | 1216 | 0.050 |
Why?
|
Competency-Based Education | 1 | 2022 | 211 | 0.050 |
Why?
|
Phenylalanine | 2 | 2002 | 365 | 0.050 |
Why?
|
Menstrual Cycle | 1 | 2004 | 551 | 0.050 |
Why?
|
Mice, Inbred ICR | 1 | 2021 | 352 | 0.050 |
Why?
|
Pentylenetetrazole | 1 | 2000 | 69 | 0.050 |
Why?
|
Models, Anatomic | 2 | 2001 | 691 | 0.050 |
Why?
|
Visual Pathways | 1 | 2005 | 565 | 0.050 |
Why?
|
Contractile Proteins | 1 | 2001 | 246 | 0.050 |
Why?
|
Child | 10 | 2022 | 77709 | 0.050 |
Why?
|
North America | 1 | 2003 | 1249 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2011 | 63114 | 0.040 |
Why?
|
Denervation | 1 | 2000 | 278 | 0.040 |
Why?
|
Sweetening Agents | 1 | 2002 | 296 | 0.040 |
Why?
|
Extracellular Space | 1 | 2021 | 594 | 0.040 |
Why?
|
Androgens | 1 | 2006 | 1281 | 0.040 |
Why?
|
Cerebral Ventricles | 1 | 2001 | 544 | 0.040 |
Why?
|
Pons | 1 | 2000 | 245 | 0.040 |
Why?
|
Image Enhancement | 2 | 2000 | 2921 | 0.040 |
Why?
|
Medulla Oblongata | 1 | 2000 | 243 | 0.040 |
Why?
|
Gyrus Cinguli | 1 | 2005 | 1091 | 0.040 |
Why?
|
Boston | 2 | 2008 | 9313 | 0.040 |
Why?
|
Death, Sudden | 1 | 2000 | 302 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2009 | 13989 | 0.040 |
Why?
|
X Chromosome | 1 | 2001 | 814 | 0.040 |
Why?
|
Synapses | 1 | 2007 | 1728 | 0.040 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2000 | 257 | 0.040 |
Why?
|
Attitude to Health | 2 | 2004 | 2052 | 0.040 |
Why?
|
Apraxias | 1 | 1998 | 64 | 0.040 |
Why?
|
Decision Making | 2 | 2008 | 3887 | 0.040 |
Why?
|
Somatosensory Cortex | 1 | 2021 | 528 | 0.040 |
Why?
|
Locus Coeruleus | 1 | 1998 | 176 | 0.040 |
Why?
|
Respiration Disorders | 1 | 2000 | 371 | 0.040 |
Why?
|
Oximetry | 1 | 2000 | 471 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2010 | 12026 | 0.040 |
Why?
|
Life Style | 1 | 2008 | 3835 | 0.040 |
Why?
|
Form Perception | 1 | 1997 | 182 | 0.040 |
Why?
|
Rats | 4 | 2000 | 24260 | 0.030 |
Why?
|
Cricetinae | 1 | 2000 | 2472 | 0.030 |
Why?
|
Linear Models | 3 | 2013 | 5952 | 0.030 |
Why?
|
Odds Ratio | 1 | 2009 | 9849 | 0.030 |
Why?
|
Psychological Tests | 1 | 1998 | 651 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2001 | 1152 | 0.030 |
Why?
|
Writing | 1 | 1998 | 206 | 0.030 |
Why?
|
Postoperative Complications | 3 | 2009 | 15295 | 0.030 |
Why?
|
Neurologic Examination | 2 | 1993 | 930 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2021 | 2375 | 0.030 |
Why?
|
Tissue Distribution | 1 | 1999 | 2327 | 0.030 |
Why?
|
Attention | 3 | 2006 | 2400 | 0.030 |
Why?
|
Sexual Behavior | 1 | 2004 | 2057 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2010 | 8949 | 0.030 |
Why?
|
Amobarbital | 2 | 1991 | 43 | 0.030 |
Why?
|
Outpatients | 1 | 2002 | 1486 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2008 | 3507 | 0.030 |
Why?
|
Encephalitis | 1 | 1997 | 423 | 0.030 |
Why?
|
Abnormalities, Multiple | 1 | 2001 | 1416 | 0.030 |
Why?
|
Endocrine System Diseases | 2 | 1986 | 248 | 0.030 |
Why?
|
Nerve Net | 1 | 2006 | 2174 | 0.030 |
Why?
|
Pulmonary Fibrosis | 1 | 1998 | 530 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2010 | 15540 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2000 | 1782 | 0.030 |
Why?
|
Sphenoid Sinus | 1 | 1993 | 99 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 1998 | 2029 | 0.030 |
Why?
|
Motor Activity | 2 | 2020 | 2714 | 0.030 |
Why?
|
Encephalitis, Tick-Borne | 1 | 1993 | 34 | 0.030 |
Why?
|
Clonazepam | 1 | 1993 | 136 | 0.030 |
Why?
|
Electric Stimulation Therapy | 2 | 2009 | 605 | 0.030 |
Why?
|
Choice Behavior | 2 | 2011 | 803 | 0.030 |
Why?
|
Skull | 2 | 2010 | 813 | 0.030 |
Why?
|
Cues | 2 | 2010 | 873 | 0.030 |
Why?
|
Cerebrovascular Disorders | 1 | 1999 | 1504 | 0.030 |
Why?
|
Amnesia | 1 | 1994 | 248 | 0.030 |
Why?
|
Animals | 8 | 2021 | 168757 | 0.030 |
Why?
|
Affect | 2 | 2002 | 1476 | 0.030 |
Why?
|
Secretory Rate | 1 | 1991 | 82 | 0.030 |
Why?
|
Aphasia, Broca | 1 | 1991 | 50 | 0.020 |
Why?
|
Equipment Design | 1 | 2000 | 3582 | 0.020 |
Why?
|
Dendrites | 1 | 1994 | 485 | 0.020 |
Why?
|
UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 2011 | 68 | 0.020 |
Why?
|
Entropy | 1 | 2012 | 209 | 0.020 |
Why?
|
Aphasia | 1 | 1993 | 179 | 0.020 |
Why?
|
Software | 2 | 2017 | 4443 | 0.020 |
Why?
|
Aromatase | 1 | 1991 | 146 | 0.020 |
Why?
|
Neurofibromatosis 1 | 1 | 1996 | 569 | 0.020 |
Why?
|
Wakefulness | 1 | 2018 | 1245 | 0.020 |
Why?
|
Incidence | 1 | 2008 | 20947 | 0.020 |
Why?
|
Cohort Studies | 2 | 2011 | 40561 | 0.020 |
Why?
|
Electrocardiography | 2 | 2000 | 6442 | 0.020 |
Why?
|
Dopamine beta-Hydroxylase | 2 | 2000 | 75 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2003 | 3022 | 0.020 |
Why?
|
Engineering | 1 | 2009 | 58 | 0.020 |
Why?
|
Lung Transplantation | 1 | 1998 | 1153 | 0.020 |
Why?
|
Electric Conductivity | 1 | 2010 | 411 | 0.020 |
Why?
|
Cerebellar Neoplasms | 1 | 1994 | 587 | 0.020 |
Why?
|
Demography | 2 | 2004 | 1656 | 0.020 |
Why?
|
Tomography, Optical | 1 | 2009 | 126 | 0.020 |
Why?
|
Theft | 1 | 1988 | 19 | 0.020 |
Why?
|
Dehydroepiandrosterone | 2 | 2006 | 252 | 0.020 |
Why?
|
Models, Neurological | 2 | 2010 | 1774 | 0.020 |
Why?
|
Medulloblastoma | 1 | 1994 | 683 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2010 | 552 | 0.020 |
Why?
|
Neurotoxins | 1 | 2009 | 237 | 0.020 |
Why?
|
Polysomnography | 1 | 1995 | 1776 | 0.020 |
Why?
|
Precipitating Factors | 1 | 2008 | 52 | 0.020 |
Why?
|
Organ Specificity | 1 | 1993 | 2008 | 0.020 |
Why?
|
Heart Rate | 1 | 1999 | 4091 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 1999 | 11366 | 0.020 |
Why?
|
Georgia | 1 | 2008 | 186 | 0.020 |
Why?
|
Epilepsy, Reflex | 1 | 2008 | 26 | 0.020 |
Why?
|
Testicular Neoplasms | 1 | 1994 | 804 | 0.020 |
Why?
|
Finite Element Analysis | 1 | 2010 | 431 | 0.020 |
Why?
|
Cerebral Infarction | 1 | 1993 | 1011 | 0.020 |
Why?
|
Psychosurgery | 1 | 1988 | 87 | 0.020 |
Why?
|
Feedback | 1 | 1991 | 795 | 0.020 |
Why?
|
Androstanes | 1 | 2006 | 21 | 0.020 |
Why?
|
Administration, Oral | 1 | 1995 | 3913 | 0.020 |
Why?
|
Facial Expression | 1 | 1991 | 508 | 0.020 |
Why?
|
Vision, Ocular | 1 | 1990 | 464 | 0.020 |
Why?
|
Ambulatory Care | 1 | 1998 | 2708 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 1995 | 4933 | 0.020 |
Why?
|
Neonatal Screening | 1 | 2011 | 591 | 0.020 |
Why?
|
Cerebrospinal Fluid | 1 | 2010 | 534 | 0.020 |
Why?
|
Cognition Disorders | 2 | 2003 | 4043 | 0.020 |
Why?
|
Nurse's Role | 1 | 2008 | 209 | 0.020 |
Why?
|
Pregnancy | 2 | 2022 | 29144 | 0.020 |
Why?
|
Enzyme Induction | 1 | 2006 | 475 | 0.020 |
Why?
|
Education | 1 | 2009 | 543 | 0.020 |
Why?
|
Brain Neoplasms | 3 | 2016 | 8863 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1998 | 10943 | 0.020 |
Why?
|
Biological Availability | 1 | 2006 | 397 | 0.020 |
Why?
|
Stereotaxic Techniques | 1 | 1988 | 536 | 0.020 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2006 | 187 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1995 | 6038 | 0.020 |
Why?
|
Radiography | 2 | 1993 | 7023 | 0.020 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2009 | 721 | 0.010 |
Why?
|
Blood Glucose | 1 | 1998 | 6256 | 0.010 |
Why?
|
Drug Resistance | 1 | 2009 | 1609 | 0.010 |
Why?
|
Photic Stimulation | 2 | 2003 | 2025 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 21827 | 0.010 |
Why?
|
Orientation | 1 | 2005 | 327 | 0.010 |
Why?
|
Muscles | 1 | 1988 | 1614 | 0.010 |
Why?
|
Visual Field Tests | 1 | 2005 | 383 | 0.010 |
Why?
|
Internal-External Control | 1 | 2004 | 363 | 0.010 |
Why?
|
Corpus Callosum | 1 | 1988 | 737 | 0.010 |
Why?
|
Electromyography | 1 | 1988 | 1379 | 0.010 |
Why?
|
Neurosurgery | 1 | 2009 | 643 | 0.010 |
Why?
|
Memory, Short-Term | 1 | 2009 | 975 | 0.010 |
Why?
|
Judgment | 1 | 2005 | 281 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 21746 | 0.010 |
Why?
|
Neurodegenerative Diseases | 1 | 2011 | 1061 | 0.010 |
Why?
|
Pilot Projects | 1 | 1995 | 8324 | 0.010 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2004 | 292 | 0.010 |
Why?
|
Methanol | 1 | 2002 | 85 | 0.010 |
Why?
|
Personal Satisfaction | 1 | 2006 | 643 | 0.010 |
Why?
|
Survival Analysis | 1 | 1994 | 10252 | 0.010 |
Why?
|
Glioma | 1 | 2016 | 3401 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2001 | 335 | 0.010 |
Why?
|
Risk Factors | 1 | 2008 | 72290 | 0.010 |
Why?
|
Endocrine System | 1 | 2002 | 113 | 0.010 |
Why?
|
Nonlinear Dynamics | 1 | 2004 | 502 | 0.010 |
Why?
|
Neural Inhibition | 1 | 2005 | 602 | 0.010 |
Why?
|
Receptors, Catecholamine | 1 | 2000 | 6 | 0.010 |
Why?
|
Phenylethanolamine N-Methyltransferase | 1 | 2000 | 18 | 0.010 |
Why?
|
Polycystic Ovary Syndrome | 1 | 1984 | 370 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2010 | 2716 | 0.010 |
Why?
|
Phenotype | 2 | 2011 | 16365 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 2006 | 1178 | 0.010 |
Why?
|
Employment | 1 | 2006 | 1132 | 0.010 |
Why?
|
Oscillometry | 1 | 1999 | 147 | 0.010 |
Why?
|
Emotions | 1 | 1991 | 2661 | 0.010 |
Why?
|
Goals | 1 | 2004 | 706 | 0.010 |
Why?
|
Neural Pathways | 1 | 2010 | 2972 | 0.010 |
Why?
|
Visual Fields | 1 | 2005 | 1047 | 0.010 |
Why?
|
Prospective Studies | 3 | 2010 | 53288 | 0.010 |
Why?
|
Kainic Acid | 1 | 1998 | 199 | 0.010 |
Why?
|
Down-Regulation | 1 | 2005 | 3002 | 0.010 |
Why?
|
Nanoparticles | 1 | 2009 | 1905 | 0.010 |
Why?
|
Pediatrics | 1 | 2013 | 3475 | 0.010 |
Why?
|
Visual Cortex | 1 | 2006 | 1149 | 0.010 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2002 | 430 | 0.010 |
Why?
|
Observer Variation | 1 | 2003 | 2593 | 0.010 |
Why?
|
DNA Primers | 1 | 2001 | 2892 | 0.010 |
Why?
|
Genotype | 1 | 2011 | 12951 | 0.010 |
Why?
|
Diencephalon | 1 | 1996 | 56 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2002 | 1375 | 0.010 |
Why?
|
Program Evaluation | 1 | 2004 | 2488 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10397 | 0.010 |
Why?
|
Aging | 2 | 2005 | 8664 | 0.010 |
Why?
|
Disease Progression | 1 | 2011 | 13284 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2004 | 2278 | 0.010 |
Why?
|
Mice | 1 | 2021 | 81183 | 0.010 |
Why?
|
Headache | 1 | 2002 | 1226 | 0.010 |
Why?
|
Child, Preschool | 1 | 2016 | 41006 | 0.010 |
Why?
|
Follicle Stimulating Hormone | 2 | 1986 | 744 | 0.010 |
Why?
|
Regression Analysis | 1 | 2003 | 6459 | 0.010 |
Why?
|
Drug Hypersensitivity | 1 | 2002 | 884 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2008 | 4245 | 0.010 |
Why?
|
Atrophy | 1 | 1997 | 1583 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2001 | 4186 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 1988 | 20129 | 0.010 |
Why?
|
Myelin Sheath | 1 | 1996 | 652 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2004 | 3396 | 0.010 |
Why?
|
Brain Injuries | 1 | 2004 | 2025 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2011 | 25625 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2001 | 2585 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2004 | 7785 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 1990 | 193 | 0.010 |
Why?
|
Weight Loss | 1 | 2002 | 2622 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1994 | 1525 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 1994 | 1423 | 0.010 |
Why?
|
Staining and Labeling | 1 | 1994 | 1100 | 0.010 |
Why?
|
Pulsatile Flow | 1 | 1990 | 332 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 1993 | 11725 | 0.010 |
Why?
|
Antigens | 1 | 1994 | 1466 | 0.010 |
Why?
|
Drug Tolerance | 1 | 1989 | 376 | 0.000 |
Why?
|
Videotape Recording | 1 | 1988 | 352 | 0.000 |
Why?
|
Depression | 1 | 2006 | 7766 | 0.000 |
Why?
|
Blotting, Western | 1 | 1994 | 5179 | 0.000 |
Why?
|
Axons | 1 | 1994 | 1684 | 0.000 |
Why?
|
Carotid Arteries | 1 | 1990 | 952 | 0.000 |
Why?
|
Autoantibodies | 1 | 1994 | 2035 | 0.000 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1989 | 1572 | 0.000 |
Why?
|
Ovarian Cysts | 1 | 1986 | 115 | 0.000 |
Why?
|
Hyperprolactinemia | 1 | 1986 | 129 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2005 | 25043 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2013 | 77449 | 0.000 |
Why?
|
Prolactin | 1 | 1986 | 669 | 0.000 |
Why?
|
Erectile Dysfunction | 1 | 1986 | 461 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1994 | 8642 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2003 | 39050 | 0.000 |
Why?
|
Hypothalamus | 1 | 1984 | 1063 | 0.000 |
Why?
|